The dehydrogenase/reductase (SDR family) member 12, commonly referred to as DHRS12, is a part of the expansive dehydrogenase/reductase protein family. This family consists of enzymes that primarily mediate oxidation-reduction processes, playing pivotal roles in various biochemical pathways. DHRS12 inhibitors, as the name suggests, are chemical entities that specifically obstruct or modulate the activity of the DHRS12 enzyme. While the exact function and pathways associated with DHRS12 remain subjects of rigorous investigation, the development and study of inhibitors serve as critical tools in elucidating these details. Inhibitors not only help to determine the enzyme's function but also contribute to understanding its interactions within complex biochemical systems.
The chemistry and design behind DHRS12 inhibitors are based on their ability to either block the active site of the enzyme or modify its conformation in a manner that diminishes or abolishes its enzymatic activity. The structural characteristics of these inhibitors are often fine-tuned to enhance specificity, aiming to mitigate off-target effects on other members of the dehydrogenase/reductase family. This specificity is crucial because the broader family consists of several enzymes, each having unique and essential roles. By dissecting the biochemistry of DHRS12 through the lens of these inhibitors, researchers gain insights into the molecular intricacies of metabolism, cellular signaling, and various fundamental biological processes. As the field progresses, a deeper understanding of these inhibitors will continue to shed light on the broader tapestry of cellular biochemistry and the nuanced roles that enzymes like DHRS12 play within it.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Inhibits aldehyde dehydrogenase, preventing the conversion of acetaldehyde to acetate during alcohol metabolism. Theoretically, given its mode of action, it might inhibit DHRS12. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Primarily known as an antidiabetic, metformin inhibits mitochondrial glycerophosphate dehydrogenase, affecting hepatic gluconeogenesis. Given its impact on related enzymes, it has potential to inhibit DHRS12. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
ubiquinone oxidoreductase), preventing the transfer of electrons from NADH to ubiquinone. Due to its broad action on dehydrogenases, it theoretically might inhibit DHRS12. | ||||||
Raloxifene | 84449-90-1 | sc-476458 | 1 g | $802.00 | 3 | |
Raloxifene inhibits 17β-hydroxysteroid dehydrogenase type 10, impacting steroid metabolism. Its action on related enzymes suggests it could theoretically inhibit DHRS12. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate, a lipid-lowering agent, also inhibits 11β-hydroxysteroid dehydrogenase type 1, affecting cortisol metabolism. Theoretically, given its mode, it might inhibit DHRS12. | ||||||
Chlorpropamide | 94-20-2 | sc-234350 | 25 g | $73.00 | 7 | |
Chlorpropamide affects aldehyde dehydrogenase and insulin secretion, with a known impact on alcohol metabolism. Theoretically, it might inhibit DHRS12. | ||||||
3-Nitropropionic acid | 504-88-1 | sc-214148 sc-214148A | 1 g 10 g | $82.00 $459.00 | ||
This compound is known to inhibit succinate dehydrogenase in the citric acid cycle. Its mechanism suggests a theoretical chance to inhibit DHRS12. | ||||||
Fomepizole | 7554-65-6 | sc-252838 | 1 g | $75.00 | 1 | |
Fomepizole is specifically an inhibitor of alcohol dehydrogenase. Given its specific mode against dehydrogenases, there's a theoretical chance it might inhibit DHRS12. | ||||||
6-Aminonicotinamide | 329-89-5 | sc-278446 sc-278446A | 1 g 5 g | $156.00 $398.00 | 3 | |
This compound blocks 6-phosphogluconate dehydrogenase in the pentose phosphate pathway. Based on its known targets, it theoretically might inhibit DHRS12. | ||||||